Improving Hepatitis C Treatment in Injection Drug Users
Hepatitis C, Liver Diseases, Drug Abuse
About this trial
This is an interventional treatment trial for Hepatitis C focused on measuring behavior modification, health care service utilization, hepatitis C,, injection drug use, therapy compliance, alcoholism, alcohol abuse, prevention, drug abuse, liver disorder, HCV, methadone
Eligibility Criteria
Inclusion Criteria: 18-65 years of age. Enrolled in outpatient methadone maintenance treatment for greater than 3 months. Hepatitis C RNA positive. Willingness to accept HCV treatment. Subject has non-VA (Veteran's Administration) medical insurance or is willing to bear any and all expenses associated with Hepatitis C medical treatment. Exclusion Criteria: In need of inpatient drug or alcohol detoxification. Currently receiving the standard Hepatitis C treatment Unable to give adequate informed consent. Pregnant, nursing, or planning to become pregnant during HCV treatment or within 6 months following completion of treatment. Male subject who has a female sexual partner who is pregnant or planning to become pregnant at any time during HCV treatment or within 6 months following completion of treatment. Female subject or male subject who has a female sexual partner who is of child bearing years and not using two medically approved forms of contraception. Subject has made a commitment to attend residential care psychiatric or drug/alcohol rehabilitation, which would lead to unavailability to attend regularly scheduled medical care and research visits. Subject did not attend all required screening appointments. Subject has a legal proceeding whose outcome may lead to incarceration within 3 months of intake.
Sites / Locations
- Crouse Chemical Dependency Treatment Services
- SUNY Upstate Medical University - Department of Gastroenterology
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
On-site (MMT Clinic) HCV evaluation and treatment
Off-site (GI Clinic) HCV evaluation and treatment